# Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex

> **NCT06054217** · PHASE2 · UNKNOWN · sponsor: **Tarsus Pharmaceuticals, Inc.** · enrollment: 36 (estimated)

## Conditions studied

- Meibomian Gland Dysfunction
- Demodex Infestation of Eyelid
- Blepharitis
- Demodectic Blepharitis

## Interventions

- **DRUG:** Vehicle of TP-03

## Key facts

- **NCT ID:** NCT06054217
- **Lead sponsor:** Tarsus Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-01
- **Primary completion:** 2024-06-15
- **Final completion:** 2024-06-15
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2024-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06054217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06054217, "Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06054217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*